Spectrum: Autism Research News

As the Trump administration promises to deport a broader range of people, parents of chronically ill children are seeking help to stay in the country.

After weeks of will-they-or-won’t-they tensions, the House managed to pass its Republican replacement for the Affordable Care Act yesterday by a razor-thin margin.

Children with chronic conditions are especially vulnerable to health insurance changes, as they often rely on specialists and medications that may not be covered if they switch plans.

Eight pharmaceutical companies more than doubled their lobbying spending in the first three months of 2017.

Facing acute risks to their businesses from Washington policymakers, health companies spent more than $2 million to buy access to the incoming Trump administration via candlelight dinners, black-tie balls and other inauguration events.

Both the Pharmaceutical Research and Manufacturers of America and the nonprofit group have gone to great lengths to show that drugmakers are not driving what they describe as a “grass-roots” effort to fight imports.

Michigan’s experience demonstrates a way for governments to increase immunization rates without having to address religious or philosophical opposition to vaccines.

Critics say vulnerable patients are being manipulated and the goals promoted are skewed by the pharma benefactors who want faster government approval for new products.

Nine U.S. senators are pushing the U.S. Attorney General to reveal what he knows about a reported investigation into Tom Price’s stock trades that a top federal prosecutor might have begun before being fired by the Trump administration.

Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act.